pindolol has been researched along with nifedipine in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (39.39) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 7 (21.21) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amrein, R; Castagnoli, E; Chu, D; Cocco, G; Strozzi, C | 2 |
| Murooka, H; Ozawa, T; Tamura, K | 1 |
| Clifton, GD; DeMaria, AN; Harrison, MR | 1 |
| Hua, C; Kelly, MT; Smyth, MR; Telting-Diaz, M | 1 |
| Basciu, M; Cherchi, A; Pili, G; Sau, F; Seguro, C; Siddi, PP; Tamponi, R | 1 |
| Baldenkov, GN; Bocharova, OI; Kozlov, SG; Liakishev, AA; Orekhov, AN; Ruda, MIa; Tertov, VV | 1 |
| Garcia, ML; Kaczorowski, GJ; King, VF; Reuben, JP; Siegl, PK | 1 |
| Bräutigam, M; Welzel, D | 1 |
| Malta, E; Molenaar, P | 1 |
| Kondo, N | 1 |
| Minobe, M; Mizobe, M; Nagao, T; Narita, H; Saso, Y; Suzuki, T; Yabana, H | 1 |
| Aihara, H; Chiba, S; Kaneko, K; Tsuchida, K | 1 |
| Mattioli, G; Ricci, S; Teglio, V | 1 |
| Lowenthal, DT | 1 |
| Otsuka, K; Tsukiyama, H; Yamamoto, Y | 1 |
| Fernandes, AC; Filipe, PM; Manso, CF; Silva, JM | 1 |
| Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V | 1 |
2 review(s) available for pindolol and nifedipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease; Female; Fetal Growth Retardation; Furosemide; Gestational Age; Humans; Hypertension; Incidence; Infant, Small for Gestational Age; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Perinatal Death; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Severity of Illness Index | 2020 |
3 trial(s) available for pindolol and nifedipine
| Article | Year |
|---|---|
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Nitroglycerin; Physical Exertion; Pindolol; Pyridines | 1979 |
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidone; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Indenes; Male; Middle Aged; Nifedipine; Oxprenolol; Pindolol; Propanolamines; Timolol | 1990 |
[Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Pindolol; Quality of Life; Random Allocation | 1989 |
28 other study(ies) available for pindolol and nifedipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
"Near maximal" exercise test by treadmill for evaluation of cardiac function.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Blood Pressure; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Depression, Chemical; Electrocardiography; Exercise Test; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nifedipine; Oxygen Consumption; Pindolol; Trichlormethiazide | 1979 |
Hemodynamic effects of calcium channel and beta-receptor antagonists: evaluation by Doppler echocardiography.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Echocardiography, Doppler; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Nifedipine; Pindolol; Propranolol; Verapamil | 1991 |
High-performance liquid chromatographic determination of nifedipine, nicardipine and pindolol using a carbon fibre flow-through amperometric detector.
Topics: Carbon; Chromatography, High Pressure Liquid; Humans; Microelectrodes; Molecular Structure; Nicardipine; Nifedipine; Pindolol | 1991 |
[Effects of beta adrenergic blocking agents and calcium antagonists on atherogenic properties of blood serum of patients with ischemic heart disease].
Topics: Adult; Cells, Cultured; Coronary Disease; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Nifedipine; Pindolol; Propranolol | 1990 |
Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzazepines; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium-Transporting ATPases; Diltiazem; Dithiothreitol; Ethylmaleimide; Female; Guinea Pigs; Hydrogen-Ion Concentration; Iodocyanopindolol; Male; Myocardium; Nifedipine; Nitrendipine; Ouabain; Pindolol; Receptors, Nicotinic; Sodium; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Temperature; Verapamil | 1986 |
Analysis of agonist dissociation constants as assessed by functional antagonism in guinea pig left atria.
Topics: Adenosine; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzofurans; Carbachol; Catechols; Gallopamil; Guinea Pigs; Heart; In Vitro Techniques; Iodine Radioisotopes; Isoproterenol; Kinetics; Male; Myocardial Contraction; Nifedipine; Pindolol; Propanolamines | 1986 |
Electromechanical effects of A23187 on guinea-pig ventricular muscle: a dual action of A23187.
Topics: Animals; Calcimycin; Calcium; Electric Stimulation; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Membrane Potentials; Myocardial Contraction; Nifedipine; Papillary Muscles; Pindolol; Ranitidine; Ryanodine | 1986 |
Hypotensive action of diltiazem in conscious renal hypertensive dogs: comparison with nifedipine and interaction with pindolol.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diltiazem; Dogs; Electrocardiography; Heart Rate; Hypertension, Renal; Male; Nifedipine; Pindolol; Time Factors | 1986 |
Cardiovascular effects of an ionophorous antibiotic, lonomycin A, in anesthetized dogs.
Topics: Animals; Anti-Bacterial Agents; Coronary Circulation; Coronary Vessels; Dogs; Female; Ionophores; Isoproterenol; Male; Nifedipine; Nigericin; Ouabain; Papaverine; Pindolol; Potassium Chloride; Vasodilation | 1985 |
[Centra, peripheral, and volumetric hemodynamic changes in the treatment of essential hypertension with calcium antagonists and beta blockaders].
Topics: Adrenergic beta-Antagonists; Calcium; Female; Hemodynamics; Humans; Hypertension; Male; Nifedipine; Pindolol | 1980 |
New drugs for hypertension.
Topics: Antihypertensive Agents; Bumetanide; Diltiazem; Dipeptides; Enalapril; Guanabenz; Guanidines; Humans; Indapamide; Labetalol; Nifedipine; Pindolol; Verapamil | 1984 |
Effect of pindolol and nifedipine alone and in combination on haemodynamic parameters/variables in essential hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nifedipine; Pindolol; Vascular Resistance | 1984 |
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; Nifedipine; Pindolol; Pyridines | 1980 |
[Therapeutic aspects of a case of Prinzmetal's angina].
Topics: Aged; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Drug Therapy, Combination; Electrocardiography; Humans; Male; Nifedipine; Nitrates; Pindolol; Tetrahydropapaveroline | 1980 |
[Antioxidant effect of drugs used in cardiovascular therapy].
Topics: Adrenergic beta-Antagonists; Antioxidants; Ascorbic Acid; Atenolol; Calcium Channel Blockers; Copper; Female; Fluorescence; Humans; Lipid Peroxidation; Male; Metoprolol; Nifedipine; Pindolol; Propranolol | 1998 |